Novartis Institutes for Biomedical Research
Dr. M Guérard is affiliated to F. Hoffmann La Roche Ltd., Novartis Institutes for Biomedical Research. Dr. M Guérard is currently providing services as Professor. Dr. M Guérard has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. M Guérard contributions have acclaimed recognition from honourable subject experts around the world. Dr. M Guérard is actively associated with different societies and academies. Dr. M Guérard academic career is decorated with several reputed awards and funding. Dr. M Guérard research interests include F. Hoffmann La Roche Ltd..
Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models.